Read + Share
. Correction to "An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in
the renal capillaries and protects the capillary network in the diabetic rats". Diabetes Obes Metab 2025 Dec 9. doi: 10.1111/dom.70372.
PMID: 41366629
|
 |
|
. Correction to "An SGLT2 inhibitor, canagliflozin, reduces blood glucose level in
the renal capillaries and protects the capillary network in the diabetic rats". Diabetes Obes Metab 2025 Dec 9. doi: 10.1111/dom.70372.
PMID: 41366629
|
|
|
|